These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 392656)

  • 1. [Treatment with antiplatelet drugs. Current status of knowledge].
    Dettori AG; Pini M; Quintavalla R
    Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
    Verstraete M
    Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
    [No Abstract]   [Full Text] [Related]  

  • 3. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet agents: a review.
    Gantmacher ML
    J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet suppressive therapy.
    Turpie AG; Hirsh J
    Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy: antiplatelet therapy (second of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(25):1403-6. PubMed ID: 349388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet function inhibitors: their clinical use.
    Fuster V; Didisheim P
    Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of common antiplatelet drugs for vascular diseases.
    Pagano T; Nair CK; Sketch MH
    Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current clinical results of antiplatelet medication].
    Ordinas A
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs in the treatment of thrombo-embolic disease--part I.
    Bouchier-Hayes D
    Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating thromboembolic disease.
    Deykin D; Gurewich V; Harker L; Hirsch J
    Geriatrics; 1977 Oct; 32(10):119-21, 125-8. PubMed ID: 302814
    [No Abstract]   [Full Text] [Related]  

  • 19. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet agents in coronary disease: are they of prophylactic value?
    Verstraete M
    Drugs; 1978 Jun; 15(6):464-71. PubMed ID: 657992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.